Why is Ipca Labs falling/rising?

As of 25-Sep, Ipca Laboratories Ltd is currently priced at 1,348.50, reflecting a decrease of 2.1 points or 0.16%. The stock has been on a downward trend, having fallen for the last four consecutive days, resulting in a total decline of 5.68% during this period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish sentiment. Despite outperforming its sector by 0.7% today, the stock's year-to-date performance shows a significant decline of 20.28%, while it has underperformed the benchmark Sensex, which has gained 3.87% year-to-date. The company has a low debt-to-equity ratio and has reported positive results over the last five quarters, with a notable increase in profits. However, the stock's long-term growth prospects appear limited, as indicated by the annual growth rate of operating profit at just 4.56% over the past five years.
In the broader market context, while Ipca Laboratories has outperformed the sector slightly today, its short-term return of +0.26% over the past week contrasts sharply with the Sensex's decline of 2.23% during the same period. This suggests that the stock is facing challenges despite some positive financial indicators, such as a high return on capital employed and a favorable price-to-earnings growth ratio. The significant drop in delivery volume, which has decreased by 71.61% against the 5-day average, also points to falling investor participation, further contributing to the stock's downward movement. Overall, while the company has strong fundamentals, the market's perception and recent trading activity indicate a cautious outlook for Ipca Laboratories Ltd.